Nifty

:

23659.00

Sensex

:

75318.39

41.00 (0.17%)
117.54 (0.16%)

Login

Nifty
Sensex

:
:

23659.00
75318.39

41.00 (0.17%)
117.54 (0.16%)

Supriya Lifescience Ltd.

Pharmaceuticals & Drugs

Rating :

75/99

BSE: 543434 | NSE: SUPRIYA

Watchlist

NSE BSE

725.25

20-May-2026

Open
High
Low
Previous Close

722.85
731.9
711
720.60

Volume
Traded Value (lacs)
52 Week High
52 Week Low

150604
108999150.95
832.4
545.5

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

5,839.83
31.52
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

5,736.62
0.14%
5.16

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

15.10
12.23
14.75

EBITDA CAGR (%)

10 Years
5 Years
3 Years

29.51
8.55
15.23

PAT CAGR (%)

10 Years
5 Years
3 Years

41.87
8.75
27.89

P:E (Median)

8 Years
5 Years
3 Years

-
26.27
28.91

P:BV (Average)

8 Years
5 Years
3 Years

-
4.27
4.62

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-
16.60
18.35

Earnings Forecasts:

(Updated: 16-05-2026)

Description 2024 2025 2026 2027
Adj EPS
P/E Ratio
Revenue
EBITDA
Net Income
ROA
P/B Ratio
ROE
FCFF
FCFF Yield
Net Debt
BVPS

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var% Mar 25 Mar 24 Var%
Net Sales 206.44 185.65 11.20% 199.83 166.10 20.31% 145.07 160.63 -9.69% 184.11 158.18 16.39%
Expenses 134.36 119.70 12.25% 127.19 101.39 25.45% 93.37 98.08 -4.80% 116.52 102.68 13.48%
EBITDA 72.08 65.95 9.29% 72.65 64.72 12.25% 51.70 62.54 -17.33% 67.58 55.50 21.77%
EBIDTM 34.92% 35.53% 36.35% 38.96% 35.64% 38.94% 36.71% 35.09%
Other Income 2.61 2.10 24.29% 2.73 2.52 8.33% 2.67 2.22 20.27% 2.98 2.19 36.07%
Interest 0.49 0.51 -3.92% 0.42 0.43 -2.33% 0.51 0.34 50.00% 0.42 0.60 -30.00%
Depreciation 6.82 4.96 37.50% 6.64 4.74 40.08% 6.45 4.66 38.41% 6.08 3.91 55.50%
PBT 66.92 62.58 6.94% 68.32 62.06 10.09% 47.41 59.77 -20.68% 64.06 53.17 20.48%
Tax 17.24 15.80 9.11% 17.89 15.92 12.37% 12.62 15.13 -16.59% 13.68 16.24 -15.76%
PAT 49.67 46.78 6.18% 50.43 46.15 9.27% 34.79 44.64 -22.07% 50.38 36.93 36.42%
PATM 24.06% 25.20% 25.23% 27.78% 23.98% 27.79% 27.37% 23.35%
EPS 6.17 5.81 6.20% 6.26 5.73 9.25% 4.32 5.55 -22.16% 6.26 4.59 36.38%

Description Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var% Mar 25 Mar 24 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 735.45 696.49 570.34 460.94 530.05 391.22 311.64 277.84 212.91 183.50 170.66 Net Sales Growth 9.68% 22.12% 23.73% -13.04% 35.49% 25.54% 12.17% 30.50% 16.03% 7.52% Cost Of Goods Sold 203.52 211.18 221.74 180.81 195.80 128.13 138.48 146.87 135.50 122.98 107.43 Gross Profit 531.93 485.31 348.60 280.13 334.24 263.09 173.16 130.96 77.41 60.52 63.22 GP Margin 72.33% 69.68% 61.12% 60.77% 63.06% 67.25% 55.56% 47.14% 36.36% 32.98% 37.04% Total Expenditure 471.44 435.56 394.65 332.50 316.06 218.07 213.26 213.41 190.96 166.38 151.00 Power & Fuel Cost - 24.80 21.37 20.95 14.07 9.24 8.97 8.06 7.03 6.93 6.64 % Of Sales - 3.56% 3.75% 4.55% 2.65% 2.36% 2.88% 2.90% 3.30% 3.78% 3.89% Employee Cost - 80.52 67.64 55.58 49.08 32.76 25.59 18.97 16.30 12.61 10.48 % Of Sales - 11.56% 11.86% 12.06% 9.26% 8.37% 8.21% 6.83% 7.66% 6.87% 6.14% Manufacturing Exp. - 50.18 35.34 28.71 19.81 13.69 15.07 18.58 14.35 9.35 5.81 % Of Sales - 7.20% 6.20% 6.23% 3.74% 3.50% 4.84% 6.69% 6.74% 5.10% 3.40% General & Admin Exp. - 27.54 21.66 16.73 11.23 8.87 9.30 6.93 8.03 8.17 10.15 % Of Sales - 3.95% 3.80% 3.63% 2.12% 2.27% 2.98% 2.49% 3.77% 4.45% 5.95% Selling & Distn. Exp. - 34.74 22.17 24.16 22.58 23.36 13.72 11.54 9.18 2.84 3.55 % Of Sales - 4.99% 3.89% 5.24% 4.26% 5.97% 4.40% 4.15% 4.31% 1.55% 2.08% Miscellaneous Exp. - 6.60 4.73 5.56 3.49 2.02 2.12 2.45 0.57 3.50 3.55 % Of Sales - 0.95% 0.83% 1.21% 0.66% 0.52% 0.68% 0.88% 0.27% 1.91% 4.06% EBITDA 264.01 260.93 175.69 128.44 213.99 173.15 98.38 64.43 21.95 17.12 19.66 EBITDA Margin 35.90% 37.46% 30.80% 27.86% 40.37% 44.26% 31.57% 23.19% 10.31% 9.33% 11.52% Other Income 10.99 9.82 10.96 9.94 7.58 5.00 11.07 8.33 8.59 7.45 2.39 Interest 1.84 1.83 5.15 3.08 4.20 4.08 6.85 10.22 10.75 11.76 10.04 Depreciation 25.99 20.44 15.81 11.81 10.12 6.76 6.38 5.43 5.33 4.75 3.95 PBT 246.71 248.48 165.69 123.49 207.24 167.31 96.23 57.10 14.46 8.06 8.06 Tax 61.43 60.52 46.58 33.63 55.44 43.72 22.82 17.68 5.74 2.40 2.37 Tax Rate 24.90% 24.36% 28.11% 27.23% 26.75% 26.13% 23.71% 30.96% 39.70% 29.78% 29.40% PAT 185.27 187.96 119.11 89.86 151.81 123.59 73.40 39.42 8.73 5.66 5.69 PAT before Minority Interest 185.27 187.96 119.11 89.86 151.81 123.59 73.40 39.42 8.73 5.66 5.69 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 25.19% 26.99% 20.88% 19.49% 28.64% 31.59% 23.55% 14.19% 4.10% 3.08% 3.33% PAT Growth 6.17% 57.80% 32.55% -40.81% 22.83% 68.38% 86.20% 351.55% 54.24% -0.53% EPS 23.01 23.35 14.80 11.16 18.86 15.35 9.12 4.90 1.08 0.70 0.71

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 996.76 815.37 699.46 615.69 268.58 149.19 93.79 54.66 45.89 41.72 Share Capital 16.10 16.10 16.10 16.10 14.64 14.64 14.64 14.64 14.64 14.64 Total Reserves 980.66 799.27 683.36 599.59 253.95 134.56 79.15 40.02 31.25 26.04 Non-Current Liabilities 33.39 28.98 25.04 19.38 30.86 31.85 24.36 44.86 51.30 39.21 Secured Loans 0.00 0.00 0.00 0.00 0.00 2.39 8.14 35.33 43.78 30.57 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.62 3.84 Long Term Provisions 1.32 0.80 5.88 2.93 1.30 1.03 0.69 0.58 0.00 0.00 Current Liabilities 87.19 79.57 95.78 99.70 146.02 155.39 134.91 145.88 144.15 150.26 Trade Payables 74.55 59.57 64.23 48.97 51.02 49.39 44.13 41.75 40.69 49.79 Other Current Liabilities 11.46 19.64 9.50 22.61 11.48 25.67 8.24 14.82 5.94 4.21 Short Term Borrowings 0.00 0.00 16.63 21.30 67.41 76.68 77.21 85.74 94.67 94.69 Short Term Provisions 1.19 0.37 5.42 6.82 16.11 3.64 5.33 3.56 2.84 1.57 Total Liabilities 1,117.34 923.92 820.28 734.77 445.46 336.43 253.06 245.40 241.34 231.19 Net Block 452.87 310.13 261.54 189.77 100.04 97.99 84.68 91.01 88.78 75.45 Gross Block 534.00 370.82 306.49 222.92 123.06 114.08 94.56 95.58 97.53 89.25 Accumulated Depreciation 81.13 60.69 44.95 33.14 23.03 16.08 9.88 4.57 8.75 13.80 Non Current Assets 675.28 523.43 355.39 237.22 180.00 138.44 120.39 125.82 126.31 102.29 Capital Work in Progress 148.01 148.82 67.63 43.41 78.79 40.21 35.35 34.38 35.58 25.18 Non Current Investment 63.24 63.80 25.30 0.05 0.05 0.05 0.05 0.12 0.10 0.10 Long Term Loans & Adv. 11.15 0.68 0.93 3.98 1.13 0.18 0.30 0.32 1.84 1.55 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 442.07 400.48 464.89 497.54 265.46 197.99 132.66 119.57 115.04 128.91 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 118.35 85.25 115.77 92.31 72.48 49.46 30.73 31.70 38.22 53.04 Sundry Debtors 134.36 111.68 84.66 115.18 73.50 52.49 59.95 53.40 49.61 42.34 Cash & Bank 79.15 74.96 157.58 227.91 89.28 1.54 1.73 2.73 5.58 7.09 Other Current Assets 110.21 15.95 17.25 13.28 30.20 94.51 40.25 31.74 21.63 26.44 Short Term Loans & Adv. 99.04 112.65 89.62 48.86 26.19 93.40 39.93 31.11 20.34 25.80 Net Current Assets 354.88 320.91 369.11 397.84 119.44 42.60 -2.25 -26.30 -29.11 -21.35 Total Assets 1,117.35 923.91 820.28 734.76 445.46 336.43 253.05 245.39 241.35 231.20

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 164.68 113.31 63.61 48.80 75.89 116.06 48.88 27.75 27.30 13.50 PBT 248.48 165.69 123.49 207.24 167.31 96.23 57.10 14.46 8.06 8.06 Adjustment 13.73 2.40 4.61 6.87 5.39 10.24 12.67 15.78 16.47 13.30 Changes in Working Capital -38.36 -17.14 -33.81 -104.35 -66.82 36.60 -6.80 0.80 2.87 -6.74 Cash after chg. in Working capital 223.85 150.95 94.29 109.76 105.88 143.07 62.98 31.04 27.40 14.62 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -59.18 -37.65 -30.68 -60.96 -29.99 -27.00 -14.09 -3.29 -0.10 -0.46 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.66 Cash From Investing Activity -152.24 -173.57 -123.65 -59.82 -46.80 -24.52 4.83 -4.71 -26.61 -32.83 Net Fixed Assets -162.37 -145.52 -107.79 -64.48 -47.56 -24.38 0.05 3.15 -18.68 -32.46 Net Investments 0.56 -38.50 -25.25 0.00 0.00 0.00 0.07 -0.02 0.00 0.00 Others 9.57 10.45 9.39 4.66 0.76 -0.14 4.71 -7.84 -7.93 -0.37 Cash from Financing Activity -8.23 -22.36 -10.28 149.65 -14.52 -29.23 -49.92 -20.01 -2.21 21.36 Net Cash Inflow / Outflow 4.20 -82.63 -70.32 138.63 14.57 62.31 3.79 3.03 -1.51 2.03 Opening Cash & Equivalents 74.96 157.58 227.91 89.28 74.70 12.40 8.61 5.58 7.09 5.06 Closing Cash & Equivalent 79.15 74.96 157.58 227.91 89.28 74.70 12.40 8.61 5.58 7.09

Financial Ratios

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 123.84 101.31 86.91 76.50 36.70 101.93 64.08 37.34 27.56 23.82 ROA 18.42% 13.66% 11.56% 25.73% 31.61% 24.90% 15.82% 4.65% 2.40% 2.80% ROE 20.74% 15.73% 13.66% 34.34% 59.17% 60.42% 53.11% 22.16% 15.05% 17.20% ROCE 27.63% 22.31% 18.71% 43.34% 60.12% 49.67% 36.52% 18.63% 11.48% 12.27% Fixed Asset Turnover 1.73 1.91 1.95 3.40 3.63 3.45 3.38 3.23 2.09 2.32 Receivable days 57.43 55.39 70.62 58.51 53.35 57.07 64.39 61.89 86.01 76.12 Inventory Days 47.52 56.71 73.53 51.10 51.64 40.70 35.46 47.13 85.36 90.25 Payable days 115.90 101.89 114.26 93.20 143.03 123.24 74.29 68.83 106.73 95.88 Cash Conversion Cycle -10.96 10.21 29.89 16.41 -38.04 -25.47 25.56 40.19 64.64 70.49 Total Debt/Equity 0.00 0.00 0.02 0.03 0.26 0.55 0.96 2.39 3.47 3.70 Interest Cover 137.08 33.18 41.04 50.37 42.01 15.05 6.59 2.34 1.69 1.80

Top Investors:

cohesion mk best ideas sub-trust

aditya birla sun life insurance company limited

Annual Reports:

News Update:

Supriya Lifescience gets EIR for manufacturing facility at Lote
22nd Apr 2026, 12:28 PM

USFDA conducted an inspection at the company’s manufacturing facility located at Lote from February 02, 2026 to February 06, 2026
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback